Stock screener

INDV

Conviction 41HealthcareScan · Thu, Sep 24, 2026

Indivior Pharmaceuticals, Inc. (INDV) closed at $36.02 (+0.29%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 51, RS Rating 87, -13.9% from its 52-week high, +0.8% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

INDV$36.02+0.29%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
Vol MA14 2.1M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Indivior Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.indivior.com ↗
Price36.02
Change+0.29%
Gap+0.39%
Rel volume1.30×
Avg volume2.14M
Avg $ vol74.9M
SMA 2034.99
SMA 5037.33
SMA 20035.72
Price vs 50-3.52%
Price vs 200+0.81%
MA stackmixed
50/200 cross—
Supertrenddown · 36.99
RSI (14)51
MACD hist0.32
MACD crossbull · 7d
Stoch %K / %D72 / 75
ADX (14)32
+DI / −DI19 / 16
RSI divergenceBullish
MACD divergenceBullish
ATR %2.85%
ADR %2.53%
52w high41.83
52w low22.73
From 52w high-13.90%
Above 52w low+58.45%
New 52w highNo
SqueezeOff
Bollinger width6.62%
%B0.94
Donchian pos71.99%
Donchian high36.90
Donchian low33.74
AVWAP (52w high)37.91
vs AVWAP high-4.99%
AVWAP (52w low)34.22
vs AVWAP low+5.23%
OBV trendDown
Chaikin MF (20)0.01
Today vs 20d1.30×
Avg vol (14d)2.1M
Avg vol (20d)2.14M
Avg $ vol (20d)74.9M
Market cap4.25B
RS Rating87 / 99
RS 3m (vs SPY)-17.27%
RS 6m (vs SPY)+2.20%
RS line new highNo
Trend template6/8
Technical rank65.6
1 week+0.91%
1 month+0.13%
3 months-12.78%
6 months+19.02%
1 year+55.30%
YTD+0.80%
P/E20.24
P/B-20.43
P/S3.43
P/FCF-45.70
EPS1.64
Div yield—
ROE-100.96%
ROA17.03%
Debt/Eq-2.34
Current0.84
EV/EBITDA16.60
Gross margin80.23%
Net margin16.95%
Rev growth4.29%
EPS growth2900.00%
Price target45.50
Target upside26.34%
Analyst ratingBuy
Institutional107.96%
Ent. value4.52B
Revenue343M
Net income122M
Gross profit294M
Free cash flow-93M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out121.92M
Employees838
ListedWed, Dec 24, 2014
Free float114.59M
Float %91.8%
Short interest11.3M
Days to cover5.7d
Short volume43.6%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est$1.15 vs $0.97
Last surprise+18.6% beat
Setup gradeD
Conviction41 / 100
Pattern quality—
Tech rank65.6 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance40.59
Support33.79
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in INDV

All disclosures →
No recent disclosed trades by Congress in INDV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in INDV · open-market 2 buys · 2 sells

InsiderSideShares
Anderson Woodrow D
Chief Accounting Officer · Common Stock · 2026-08-27
Buy1.5K
Anderson Woodrow D
Chief Accounting Officer · Common Stock · 2026-08-05
Buy1.5K
Heidbreder Christian
Chief Scientific Officer · Common Stock · 2026-07-10
Sell18.59K
Preblick Ryan
Chief Financial Officer · Common Stock · 2026-06-08
Sell36K
Stejbach Mark
Director · Common Stock · 2026-05-13
Grant6.52K
Thompson Juliet
Director · Common Stock · 2026-05-13
Grant6.52K
Kingsley Stuart A
Director · Common Stock · 2026-05-13
Grant6.52K
Humphreys Keith
Director · Common Stock · 2026-05-13
Grant6.52K
Ryan Barbara
Director · Common Stock · 2026-05-13
Grant6.52K
NINIVAGGI DANIEL A
Director · Common Stock · 2026-05-13
Grant6.52K

SEC filings

EDGAR filings in INDV · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.